Clinical Trial Update: Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating bevacizumab with combination chemotherapy as first-line therapy for metastatic colorectal cancer unsuitable for surgica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: UNICANCER | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED